Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Novartis
NVS
$273B
| $253M | 0.06% |
3,279,483
+38,721
| +1% | +$2.86M |
2013 Q2
21 quarters
|
|
302
Tyler Technologies
TYL
$13.5B
| $253M | 0.06% |
1,032,052
+91,535
| +10% | +$21.8M |
2013 Q2
21 quarters
|
|
303
Cummins
CMI
$72.1B
| $252M | 0.06% |
1,727,365
+86,791
| +5% | +$12.2M |
2013 Q2
21 quarters
|
|
304
Southern Company
SO
$99.1B
| $252M | 0.06% |
5,781,699
+852,234
| +17% | +$39.3M |
2013 Q2
21 quarters
|
|
305
Welltower
WELL
$162B
| $251M | 0.06% |
3,909,305
-435,417
| -10% | -$28.1M |
2013 Q2
21 quarters
|
|
306
Trane Technologies
TT
$105B
| $251M | 0.06% |
2,453,801
-327,680
| -12% | -$32M |
2013 Q2
21 quarters
|
|
307
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
| $251M | 0.06% |
1,760,601
-33,108
| -2% | -$4.64M |
2013 Q2
21 quarters
|
|
|
ETP
308
DELISTED
Energy Transfer Partners, L.P.
ETP
| $250M | 0.06% |
11,221,357
+1,525,429
| +16% | +$33.1M |
2013 Q2
21 quarters
|
|
309
Bunge Global
BG
$19.7B
| $249M | 0.06% |
3,620,854
+3,117,218
| +619% | +$206M |
2013 Q2
21 quarters
|
|
|
VMW
310
DELISTED
VMware, Inc
VMW
| $247M | 0.06% |
1,583,357
-240,086
| -13% | -$36.7M |
2013 Q2
21 quarters
|
|
311
Rollins
ROL
$15.4B
| $246M | 0.06% |
9,118,370
-566,508
| -6% | -$14.6M |
2013 Q2
21 quarters
|
|
312
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.89B
| $245M | 0.06% |
1,547,744
+574,869
| +59% | +$87M |
2013 Q2
21 quarters
|
|
313
General Mills
GIS
$17.3B
| $244M | 0.06% |
5,688,684
+354,443
| +7% | +$16M |
2013 Q2
21 quarters
|
|
314
Thomson Reuters
TRI
$44.7B
| $243M | 0.06% |
4,583,005
+3,890,965
| +562% | +$195M |
2013 Q2
21 quarters
|
|
|
ANDV
315
DELISTED
Andeavor
ANDV
| $243M | 0.06% |
1,581,612
+910,482
| +136% | +$134M |
2013 Q2
21 quarters
|
|
316
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.68B
| $242M | 0.06% |
5,131,121
-207,677
| -4% | -$9.85M |
2015 Q1
14 quarters
|
|
317
Public Storage
PSA
$54.2B
| $241M | 0.06% |
1,196,788
-192,048
| -14% | -$41.4M |
2013 Q2
21 quarters
|
|
318
Vodafone
VOD
$36B
| $240M | 0.06% |
11,066,595
-787,226
| -7% | -$18.3M |
2013 Q2
21 quarters
|
|
319
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.1B
| $240M | 0.06% |
7,184,398
-101,250
| -1% | -$3.32M |
2013 Q4
19 quarters
|
|
320
Ventas
VTR
$42.1B
| $240M | 0.06% |
4,410,992
-255,099
| -5% | -$14.8M |
2013 Q2
21 quarters
|
|
321
JD.com
JD
$36.6B
| $239M | 0.06% |
9,170,799
+3,088,098
| +51% | +$101M |
2014 Q2
17 quarters
|
|
322
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $236M | 0.06% |
4,284,612
-1,604
| -0% | -$87.9K |
2013 Q2
21 quarters
|
|
323
iShares 7-10 Year Treasury Bond ETF
IEF
$41.5B
| $234M | 0.06% |
2,315,841
+692,423
| +43% | +$70.6M |
2013 Q2
21 quarters
|
|
324
SS&C Technologies
SSNC
$19B
| $232M | 0.06% |
4,088,152
-140,816
| -3% | -$7.81M |
2013 Q2
21 quarters
|
|
325
iShares MBS ETF
MBB
$35.6B
| $231M | 0.06% |
2,238,905
+166,178
| +8% | +$17.2M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.